340B Drug Pricing, Penalties Need To Be Implemented, Congressional Leaders Say
Leaders of key health care committees urge HRSA to move ahead quickly with regulations, which might mean implementing a 2017 final rule or issuing a new proposed rule.
You may also be interested in...
Recent developments in US federal government regulation of prescription drug pricing and reimbursement.
Azar didn’t bring much comforting news to attendees at the annual 340B Coalition conference, with a strong defense of cuts in reimbursement for providers who use the drug discount program. But he did suggest that the 'penny pricing' policy will be finalized soon.
Proposed rule will revisit controversial provisions in the January 340B final rule to address manufacturer concerns about the US discount program.